News

Eversource Energy's Upcoming Earnings Report: A Detailed Insight

Eversource Energy's Upcoming Earnings Report: A Detailed Insight

Analyzing Eversource Energy's Earnings Report

Eversource Energy (NYSE: ES) is set to announce its latest quarterly earnings soon. Investors are keeping a close eye on potential outcomes, eager to see how the company performs against market expectations.

Projected EPS and Market Sentiment

Analysts predict that Eversource will report an earnings per share (EPS) of $1.14. This anticipation suggests a keen interest among investors, who are looking for any signs of the company exceeding these estimates and offering positive guidance.

The Importance of Guidance

For new investors, understanding the significance of guidance in influencing stock prices is crucial. Information provided during earnings announcements can sway market sentiment and impact share value significantly.

Historical Earnings Performance

Looking back at the previous quarter, Eversource managed to beat EPS expectations by a narrow margin of $0.01, although this was followed by a decrease of 0.83% in share price the next day. Historical performance can give investors perspective on how the stock might react to the upcoming earnings announcement.

Detailed Earnings History

Below is a summarized view of Eversource Energy's earnings and corresponding share price reactions over past quarters:

Quarterly Summary:

Q2 2025: EPS Estimate: 0.95, EPS Actual: 0.96, Price Change: -1.00%

Q1 2025: EPS Estimate: 1.51, EPS Actual: 1.50, Price Change: 0.00%

Q4 2024: EPS Estimate: 0.99, EPS Actual: 1.01, Price Change: -3.00%

Q3 2024: EPS Estimate: 1.08, EPS Actual: 1.13, Price Change: -2.00%

Current Stock Performance

As of October 31, Eversource Energy's shares were trading at $73.81, marking an increase of 19.17% over the past year. Such strong performance suggests a positive outlook from long-term shareholders, which can be encouraging heading into the earnings release.

Analyst Insights

Market perceptions surrounding Eversource are critical for investors. Currently, 4 analyst ratings have been reported, and the consensus is favorable, rating the stock as Outperform. Furthermore, the average price target for the stock stands at $76.25, indicating a potential upside of approximately 3.31%.

Peer Comparison

Comparative analysis reveals insights into how Eversource stands against its peers, PPL and FirstEnergy:

  • PPL's average price target is $41.00 with analysts indicating a potential downside of 44.45%.
  • FirstEnergy also has a positive trajectory with a target of $50.00, suggesting a downside of 32.26%.

Comprehensive Peer Analysis

The following represents key metrics for Eversource Energy alongside its peers:

Company Performance:

Eversource Energy is leading in revenue growth with a rate of 12.02% and gross profit of $1.55B, although it lags behind peers regarding return on equity. The overall consensus remains positive.

Financial Snapshot of Eversource Energy

Market Capitalization: Eversource faces limitations compared to industry standards regarding market capitalization, with potential factors affecting growth expectations.

Revenue Growth: Impressively, Eversource Energy achieved a revenue growth rate of 12.02%, demonstrating robust performance in its sector.

Net Margin: With a noteworthy net margin of 12.43%, Eversource showcases effective cost management strategies, highlighting its financial strength.

Return on Equity: The company’s ROE of 2.28% indicates some challenges in effectively utilizing equity capital to produce optimal shareholder returns.

Debt Management: Importantly, Eversource's debt-to-equity ratio of 1.9 suggests greater reliance on debt funding, which can heighten financial risks.

Conclusion and Investment Outlook

Heading into the announcement, Eversource Energy’s prospects appear complex, indicating both strengths in revenue and concerns regarding equity returns and debt management. Investors should approach the upcoming earnings report with a balanced understanding of risks and opportunities.

Frequently Asked Questions

What is Eversource Energy's anticipated earnings per share (EPS)?

The company is expected to report an EPS of $1.14.

How has Eversource Energy's share price changed in the past year?

Shares have increased by 19.17% over the last year.

What are the general analyst ratings for Eversource Energy?

The consensus rating among analysts is Outperform, with a potential upside of 3.31% based on average price targets.

How does Eversource Energy's financial performance compare to its peers?

Eversource leads in revenue growth compared to its peers but faces challenges in return on equity.

What should investors look for in the upcoming earnings report?

Investors will be keenly observing if the company exceeds EPS expectations and provides positive future guidance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Abu Dhabi's Youth Orchestra: A Cultural Revolution

Updated Category News Views 75

A New Dawn for Abu Dhabi's Musical Future Abu Dhabi's making some noise, and I don't mean just any kind of noise. We're talking about a symphony of opportunity. The Department of Culture and Tourism – Abu Dhabi just dropped big news—setting up a dedicated institution for the Youth Orchestra Abu Dhabi. This ain't just a pat on the cultural back; it's a whole new ball...

Continue Reading
Endava Class Action: Investor Concerns Unveiled

Updated Category News Views 45

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 334

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 341

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 132

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
AppLovin Faces Securities Class Action Amid Share Plunge

Updated Category News Views 22

AppLovin's Fall from Grace AppLovin Corporation's recent tumble from investor darling to beleaguered party in a securities class action isn’t just a misstep; it’s a full-fledged nosedive into troubled waters that no trader worth their salt would want to ignore. The story kicks off with a pair of sharply disappointing turns that sent shivers down the spines of anyone...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 89

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
Boar's Head Introduces Authentic Italian Ricotta

Updated Category News Views 13

Boar's Head Brings Verona's Ricotta Stateside Imagine walking into your kitchen and finding a slice of authentic Italy sitting right there on your counter. That's what Boar's Head promises with its introduction of Italian Ricotta All Natural Cheese. It’s not just cheese; it’s a culinary passport straight from Verona, Italy, crafted using traditional techniques that...

Continue Reading
Utopia Bagels Honored at 2026 New York BagelFest

Updated Category News Views 106

From Queens Streets to Global Fame Try to picture this: a small neighborhood shop where the scent of freshly baked bagels wafts through, bringing together old friends and new generations. Now, take that local magic and multiply it by a global stage. That's the journey Utopia Bagels from Queens stepped into with massive strides over 45 years, earning a celebrated spot in...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 104

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Pricing Strategies with Pricefx Copilot's Latest Features

Updated Category News Views 159

Revolutionizing Pricing Strategies with Pricefx's Latest Release Pricefx, recognized as a global leader in AI-driven pricing software, has unveiled the highly anticipated version 14.0 of its award-winning pricing platform. This latest update, named Caribou Lou, is a transformative step in the realm of price management and optimization, designed to empower businesses to...

Continue Reading
John A. Zagat, MD Earns Pinnacle Lifetime Membership Recognition

Updated Category News Views 150

Recognizing Excellence in Mental Health Care John A. Zagat, MD, has recently been acknowledged as a Pinnacle Lifetime Member for his extensive contributions to providing comprehensive mental health care. His expertise reflects a commitment to enhancing the mental wellness of his patients through personalized strategies and innovative practices. Commitment to Quality Care...

Continue Reading
Key Leadership Appointments Transform ImprimisRx for Growth

Updated Category News Views 276

ImprimisRx Welcomes New Leadership Team Frank Mullery has stepped into the role of Chief Executive Officer at ImprimisRx, while Bridseida Cruz has taken on the position of Head of Quality. This transition is seen as a strategic move by Harrow (NASDAQ: HROW) to further cement its commitment to delivering advanced ophthalmic solutions. Meet Frank Mullery With a rich...

Continue Reading
Camila and Matthew McConaughey Embrace Godparent Role for Star Princess

Updated Category News Views 223

Camila and Matthew McConaughey: Godparents of the Star Princess The McConaugheys are set to christen Star Princess during a special Naming Ceremony. This marks a significant moment as they join a lineage of illustrious godparents for the Princess Cruises brand. A Proud Tradition Celebrated Camila and Matthew McConaughey have been chosen to be the godparents of the...

Continue Reading
Aquilius Investment Partners Partners with SS&C for Growth

Updated Category News Views 451

Aquilius Investment Partners Partners with SS&C Technologies The recent choice of fund administrator by Aquilius Investment Partners reflects a significant advancement in the strategy of SS&C Technologies in the Asia-Pacific private markets landscape. Strengthening Market Position Aquilius Investment Partners, a Singapore-based firm focused on secondary market...

Continue Reading